Astellas Obtained Approval for Vesicare OD in Japan Tokyo, October 27, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it obtained the approval of ma - Urge - Document - PDFSEARCH.IO

First Page	Meta Content
	Astellas Obtained Approval for Vesicare OD in Japan Tokyo, October 27, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it obtained the approval of ma Add to Reading List Document Date: 2010-10-26 22:39:57 Open Document File Size: 58,16 KB Share Result on Facebook City Tokyo / / Company Astellas Pharma Inc. / / Country Japan / / Event FDA Phase / / / IndustryTerm drug delivery technologies / treatment of functional symptoms / / MedicalCondition overactive bladder / gastritis / benign prostatic hyperplasia / urge incontinence / peptic ulcers / contraction of smooth muscles / / Organization Neurogenic Bladder Society / Pharmaceuticals and Medical Devices Agency / / Person Masafumi Nogimori / / / Position President and CEO / / Product Vesicare / Gaster / Water Tablet / Without Water Tablet / OAB / Vesicare OD / / Technology WOWTAB technology / drug delivery technologies / / URL http / SocialTag Incontinence Overactive bladder Muscarinic antagonists Solifenacin Urge incontinence Astellas Pharma Frequent urination Urinary bladder Benign prostatic hyperplasia Medicine

Astellas Obtained Approval for Vesicare OD in Japan Tokyo, October 27, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it obtained the approval of maAdd to Reading List